Search PDMR transactions

Notifier
Name of person with notification obligation
Stefan Nilsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Stefan Nilsson
Position
Chief Executive Officer (CEO)/Managing Directory
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Lipigon Pharmaceuticals AB
Issuer´s LEI code
549300XPO40YR12SLY87
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Subscription right/Unit right Lipigon Pharmaceuticals AB UR SE0019914110 Subscription 17,500 Quantity 3.50 SEK 11/04/2023 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Lipigon Pharmaceuticals AB UR SE0019914110 Subscription 11/04/2023 NASDAQ STOCKHOLM AB 17,500 (Quantity) 3.50 SEK
Total: 17,500
<< Back